The Artificial Intelligence in Genomics Market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029. AI is an intelligent system that performs various human intelligence-based functions such as reasoning, learning, and problem-solving skills in different disciplines such as healthcare, computer science, mathematics, and engineering. The integration of AI into the healthcare ecosystem offers benefits such as automating tasks and analyzing big patient data sets to deliver better care at lower costs. It helps diagnose diseases and identify variations in genes.
AI in genomics includes a set of software and services offered on-premises or cloud & web-based delivery modes. Integration of AI in genomics has played a significant role across functionalities like genome sequencing, genome editing, pharmacogenomics, and gene testing. The adoption of AI has increased genomic applications for speeding the process of drug discovery and development, precision medicine, diagnostics, pharmacology, and animal health.
The AI in genomics market is growing due to the growing adoption of AI across the healthcare sector and the rising focus on reducing turnaround time in drug discovery, development, and diagnostics. Further, the growing trend toward the use of personalized/precision medicine offers opportunities for the growth of this market.
The COVID-19 pandemic has become a global challenge due to the burdening healthcare systems and economies, strict isolation and quarantine protocols, limitations on social activities, restricting travel, closing borders, and shutting of businesses. COVID-19 created significant opportunities for AI in genomics for drug discovery, development, and diagnostics. Without the advancements in genomics and AI, it would have been extremely challenging for researchers to perform a comprehensive potency evaluation of drugs and vaccine candidates.
The emergence of new SARS-CoV-2 variants is hindering disease management. As per the article published in The Hindu, as of January 2022, over 6,000 mutations had occurred in the spike gene of the virus. Viral spike proteins and main proteases are the most prevalent drug discoveries and vaccine development choices. Thus, genomic analysis of COVID-19 using AI is crucial in COVID-19 drug discovery and development. For instance, in April 2020, Western University in Canada researchers used AI to identify an underlying genomic signature for 29 different DNA sequences of the SARS-CoV-2 to aid research in drug discovery and development. Thus, AI significantly boosted drug and vaccine development research for COVID-19.
Click here to: Get Free Sample Copy of this report
Rising Focus on Reducing Turnaround Time in Drug Discovery & Diagnostics
Developing and innovating new drug discovery and diagnostics are time-consuming, costly, and high-risk processes with fewer chances of a successful outcome. The drug discovery process requires 10 -15 years and costs approximately $1 billion to 2 billion. However, factors such as the lack of clinical efficiency, lack of commercial needs, and lack of drug properties reduce the chances of failure and turnaround time. Therefore, pharmaceutical manufacturers are implementing AI in the drug discovery process.
There is an urgent need to discover new drugs during the COVID-19 pandemic. Many pharmaceutical and biotechnology companies are increasingly turning to AI to improve precision and speed up drug discovery. AI has also revolutionized drug discovery processes for complex diseases such as cancer and Alzheimer’s. Therefore, the implementation of AI supports drug discovery.
The key factor influencing pharmaceutical companies to invest in AI is that the integration of AI in genomics can reduce the time required to develop a new drug. It can handle a vast amount of genomic data in addition to its use in patient matching, target identification, and forecasting. Thus, the use of AI in drug discovery can lead to the development of safe and effective drugs by supporting data-driven decision-making.
Based on offering, in 2022, the software segment is estimated to generate a large proportion of revenue
Software is used to capture, operate, and create data received from the hardware and process the data into AI systems to generate an intelligent response. AI genomics plays an important role in precision medicine, drug discovery, and diagnostics. The revenue generated from the software is a steady stream of revenue compared to services, contributing to the largest share of the market.
Based on delivery mode, the cloud-based segment is projected to register the highest CAGR over the forecast period
The growing adoption of cloud & web-based platforms and the advantages offered by the cloud-based models pertaining to security and scalability, high-capacity data storage, easy accessibility, and cost-effectiveness increase the preference for cloud-based/web-based platforms, thereby driving the market growth.
Based on functionality, in 2022, the genome sequencing segment is estimated to account for the largest share
Genome sequencing helps in the drug discovery process by accurately describing diseases and remedies associated with genetic modifications. Genome sequencing helps researchers and medical experts to understand the genetic variants and to identify the virus origin, behavior, and structure, which might help in producing vaccines, antiviral drugs, and efficient preventive strategies.
Based on application, in 2022, the drug discovery and development segment is estimated to account for the largest share
Based on application, the market is segmented into drug discovery and development, precision medicine, diagnostics, and other applications. The growing demand for innovative and new therapies for infectious or chronic diseases and the growing emphasis on quickly developing new therapies are driving the market. The integration of AI in genomics accelerates the drug discovery process and reduces the turnaround time, further offering opportunities for market growth.
Based on end user, in 2022, the pharmaceutical and biotechnological companies’ segment is estimated to account for the largest share
Pharmaceutical and biopharmaceutical companies are using AI for drug discovery and precision medicine. The pharmaceutical and biopharmaceutical companies have constant pressure to reduce the operational cost of drug manufacturing and get the therapies faster to the market. The increasing burden of chronic and infectious diseases pressurizes pharmaceutical companies for drug discovery. Thus, pharmaceutical and biopharmaceutical companies have turned to integrate AI in genomics for drug discovery by reducing development time and cost and improving efficiency.
Asia-Pacific: Fastest growing regional market
The growth in this market is attributed to factors such as the growing integration of AI in genomics across the countries like China, India, Singapore, and South Korea, increasing research initiatives in genomics, and developing infrastructure for genomic research and AI. Additionally, emerging startups and increasing funding for genomics and AI contribute to market growth in this region.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years. The key players profiled in the global AI in genomics market report are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).
Scope of the Report:
Artificial Intelligence in Genomics Market, by Offering
Artificial Intelligence in Genomics Market, by Delivery Mode
Artificial Intelligence in Genomics Market, by Functionality
Artificial Intelligence in Genomics Market, by Application
Artificial Intelligence in Genomics Market, by End User
Artificial Intelligence in Genomics Market, by Geography
Key questions answered in the report:
This study offers a detailed assessment of the AI in genomics market, including the market size & forecast for various segmentations such as offering, delivery mode, functionality, application, and end user. The AI in genomics market study also involves the value analysis of various segments of the AI in genomics market at regional and country levels.
The global AI in genomics market is projected to reach $6.22 billion by 2029, at a CAGR of 42.8% during the forecast period.
The software segment is estimated to hold the largest share in 2022. Recurring revenue from the companies owing to the subscription-based or licensing models offered by the software companies contributes to the largest market share.
The cloud & web-based segment is expected to grow at the highest CAGR over the forecast period. Growing preference for the cloud-based and web-based models owing to their advantages is a key factor for the market growth.
The growth of this market is attributed to the increasing use of AI in healthcare/genomics, growing investments, and a rising focus on reducing turnaround time in drug discovery and diagnostics. Moreover, emerging start-ups and the rising adoption of ML in personalized/precision medicine offer significant opportunities for market growth.
The key players profiled in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).
Emerging economies like China and India are projected to offer significant growth opportunities to the market players due to the availability of infrastructure for genomics research and the growing adoption of AI in genomics in these countries.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Focus on Reducing Turnaround Time in Drug Discovery
4.2.2. Increasing Investment in Genomics
4.2.3. Growing Need for and Application of AI in Genomics
4.3. Restraints
4.3.1. Limited Availability of Resources for Integration of Artificial Intelligence in Genomics
4.4. Opportunity
4.4.1. Emerging Economies
4.4.2. Rising Focus on the Development of Personalized Medicines
4.5. Challenges
4.5.1. Ambiguous Regulatory Guidelines for Genomics Software
4.5.2. Poor Security & Storage of Large Volumes of Genome Sequencing Data
4.6. Impact of COVID-19
5. Global Artificial Intelligence in Genomics Market, by Offering
5.1. Introduction
5.2. Software
5.3. Services
6. Global Artificial Intelligence in Genomics, by Delivery Mode
6.1. Introduction
6.2. Cloud & Web-based Mode
6.3. On-premise Mode
7. Global Artificial Intelligence in Genomics, by Functionality
7.1. Introduction
7.2. Genome Sequencing
7.3. Gene Editing
7.4. Other Functionalities
8. Global Artificial Intelligence in Genomics Market, by Application
8.1. Introduction
8.2. Drug Discovery & Development
8.3. Precision Medicine
8.4. Diagnostics
8.5. Other Applications
9. Global Artificial Intelligence in Genomics Market, by End User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology Companies
9.3. Academic & Research Institutes
9.4. Other End Users
10. Artificial Intelligence in Genomics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U. S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
11.4.1. NVIDIA Corporation (U.S.)
11.4.2. Microsoft Corporation (U.S.)
11.4.3. Illumina, Inc. (U.S.)
12. Company Profiles (Business Overview, Financial Overview, Solutions Portfolio, Strategic Developments)
12.1. Microsoft Corporation
12.2. NVIDIA Corporation
12.3. Deep Genomics Incorporated
12.4. Fabric Genomics, Inc.
12.5. Data4cure, Inc.
12.6. Predictive Oncology Inc.
12.7. Emedgene Technologies Ltd
12.8. Congenica Ltd.
12.9. Tempus Labs, Inc.
12.10. SOPHiA GENETICS SA
12.11. Illumina, Inc.
12.12. BenevolentAI Limited
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global AI in Genomics Market Drivers: Impact Analysis (2022–2029)
Table 2 Global AI in Genomics Market Restraints: Impact Analysis (2022–2029)
Table 3 Global AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 4 Global Artificial Intelligence in Genomics Software Market Size, by Country/Region, 2020–2029 (USD Million)
Table 5 Global AI in Genomics Services Market Size, by Country/Region, 2020–2029 (USD Million)
Table 6 Global AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 7 Global AI in Genomics Market Size for Cloud & Web-Based Mode, by Country/Region, 2020–2029 (USD Million)
Table 8 Global AI in Genomics Market Size for On-Premise Mode, by Country/Region, 2020–2029 (USD Million)
Table 9 Global AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 10 Global AI in Genomics Market Size for Genome Sequencing, by Country/Region, 2020–2029 (USD Million)
Table 11 Global AI in Genomics Market Size for Gene Editing, by Country/Region, 2020–2029 (USD Million)
Table 12 Global AI in Genomics Market Size for Other Functionalities, by Country/Region, 2020–2029 (USD Million)
Table 13 Global AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 14 Global AI in Genomics Market Size for Drug Discovery & Development, by Country/Region, 2020–2029 (USD Million)
Table 15 Global AI in Genomics Market Size for Precision Medicine, by Country/Region, 2020–2029 (USD Million)
Table 16 Global Artificial Intelligence in Genomics Market Size for Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 17 Global AI in Genomics Market Size for Other Applications, by Country/Region, 2020–2029 (USD Million)
Table 18 Global AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 19 Global AI in Genomics Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2020–2029 (USD Million)
Table 20 Global AI in Genomics Market Size for Academic & Research Institutes, by Country/Region, 2020–2029 (USD Million)
Table 21 Global AI in Genomics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million)
Table 22 Global AI in Genomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 23 North America: AI in Genomics Market Size, by Country, 2020–2029 (USD Million)
Table 24 North America: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 25 North America: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 26 North America: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 27 North America: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 28 North America: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 29 U.S.: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 30 U.S.: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 31 U.S.: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 32 U.S.: Artificial Intelligence in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 33 U.S.: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 34 Canada.: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 35 Canada: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 36 Canada: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 37 Canada: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 38 Canada.: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 39 Europe: AI in Genomics Market Size, by Country/Region, 2022–2029 (USD Million))
Table 40 Europe: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 41 Europe: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 42 Europe: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 43 Europe: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 44 Europe: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 45 Germany: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 46 Germany: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 47 Germany: Artificial Intelligence in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 48 Germany: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 49 Germany: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 50 France: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 51 France: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 52 France: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 53 France: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 54 France: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 55 U.K.: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 56 U.K.: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 57 U.K.: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 58 U.K.: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 59 U.K.: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 60 Italy: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 61 Italy: Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 62 Italy: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 63 Italy: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 64 Italy: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 65 Spain: AI in Genomics Market Size, by Offerings, 2020–2029 (USD Million)
Table 66 Spain: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 67 Spain: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 68 Spain: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 69 Spain: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 70 Rest of Europe: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 71 Rest of Europe: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 72 Rest of Europe: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 73 Rest of Europe: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 74 Rest of Europe: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 75 Asia-Pacific: AI in Genomics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 76 Asia-Pacific: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 77 Asia-Pacific: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 78 Asia-Pacific: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 79 Asia-Pacific: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 80 Asia-Pacific: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 81 China: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 82 China: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 83 China: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 84 China: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 85 China: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 86 Japan: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 87 Japan: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 88 Japan: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 89 Japan: AI in Market Size, by Application, 2020–2029 (USD Million)
Table 90 Japan: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 91 India: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 92 India: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 93 India: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 94 India: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 95 India: Artificial Intelligence in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 96 Rest of Asia Pacific: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 97 Rest of Asia Pacific: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 98 Rest of Asia Pacific: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 99 Rest of Asia Pacific: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 100 Rest of Asia Pacific: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 101 Latin America: AI in Genomics Market Size, by Country/Region, 2020-2029 (USD Million)
Table 102 Latin America: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 103 Latin America: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 104 Latin America: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 105 Latin America: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 106 Latin America: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 107 Brazil: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 108 Brazil: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 109 Brazil: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 110 Brazil: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 111 Brazil: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 112 Mexico: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 113 Mexico: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 114 Mexico: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 115 Mexico: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 116 Mexico: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 117 Rest of Latin America: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 118 Rest of Latin America: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 119 Rest of Latin America: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 120 Rest of Latin America: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 121 Rest of Latin America: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 122 Middle East & Africa: AI in Genomics Market Size, by Offering, 2020–2029 (USD Million)
Table 123 Middle East & Africa: AI in Genomics Market Size, by Delivery Mode, 2020–2029 (USD Million)
Table 124 Middle East & Africa: AI in Genomics Market Size, by Functionality, 2020–2029 (USD Million)
Table 125 Middle East & Africa: AI in Genomics Market Size, by Application, 2020–2029 (USD Million)
Table 126 Middle East & Africa: AI in Genomics Market Size, by End User, 2020–2029 (USD Million)
Table 127 Recent Developments, by Company, 2020–2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global AI in Genomics Market Size, by Offering, 2022–2029 (USD Million)
Figure 8 Global Artificial Intelligence in Genomics Market Size, by Delivery Mode, 2022–2029 (USD Million)
Figure 9 Global AI in Genomics Market Size, by Functionality, 2022–2029 (USD Million)
Figure 10 Global AI in Genomics Market Size, by Application, 2022–2029 (USD Million)
Figure 11 Global AI in Genomics Market Size, by End User, 2022–2029 (USD Million)
Figure 12 Global AI in Genomics Market, by Geography
Figure 13 Market Dynamics: AI in Genomics Market
Figure 14 Global Rise in the Number of Personalized Medicines, 2008–2020
Figure 15 Global AI in Genomics Market Size, by Offering, 2022 Vs. 2029 (USD Million)
Figure 16 Global AI in Genomics Market Size, by Delivery Mode, 2022 Vs. 2029 (USD Million)
Figure 17 Global AI in Genomics Market Size, by Functionality, 2022 Vs. 2029 (USD Million)
Figure 18 Global AI in Genomics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 19 Global AI in Genomics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 20 Global AI in Genomics Market Size, by Geography, 2022–2029 (USD Million)
Figure 21 North America: AI in Genomics Market Snapshot
Figure 22 Europe: AI in Genomics Market Snapshot
Figure 23 Asia-Pacific: AI in Genomics Market Size Snapshot
Figure 24 Latin America: AI in Genomics Market Size Snapshot
Figure 25 Key Growth Strategies Adopted by Leading Players, 2020–2022
Figure 26 AI in Genomics Market: Competitive Benchmarking by Functionality
Figure 27 AI in Genomics Market: Competitive Benchmarking by Geography
Figure 28 Market Share Analysis: AI in Genomics Market, 2021
Figure 29 Microsoft Corporation: Financial Overview (2022)
Figure 30 NVIDIA Corporation: Financial Overview (2022)
Figure 31 Predictive Oncology Inc.: Financial Overview (2021)
Figure 32 SOPHiA GENETICS SA: Financial Overview (2021)
Figure 33 Illumina, Inc.: Financial Overview (2021)
Figure 34 BenevolentAI Limited: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Mar-2023
Published Date: Feb-2018
